The National Institutes of Health is offering the R01 grant to develop clinically useful diagnostics for antimicrobial-resistant bacteria.
SynopsisVersion HistoryRelated DocumentsPackage This grant, offered by the National Institutes of Health, is for supporting milestone-driven projects aimed at developing clinically useful diagnostic platforms. The primary purpose is to identify antimicrobial-resistant bacterial pathogens and determine their associated sensitivity or resistance to antibiotics. The initiative seeks innovative diagnostic tools that can provide clinically informative insights, enhancing the fight against antimicrobial resistance. Applicants are required to submit a comprehensive Product Development Strategy, showcasing [...]